Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases
Makaleler > Tam Makale · 2014
Yazarlar: Oğuz Reşat SİPAHİ, Hasip KAHRAMAN, Sinan MERMER, Hüsnü PULLUKÇU, Meltem TAŞBAKAN, Bilgin ARDA, Tansu YAMAZHAN, Taşkın YURTSEVEN, Sohret AYDEMIR, Sercan ULUSOY
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2014, cilt 23, ss 16-19
DOI: 10.1016/j.ijid.2014.01.027
Özet
Background: Tigecycline is a relatively new glycylcycline antimicrobial, active in vitro against a variety of Gram-positive and Gram-negative organisms. In this study we evaluated the outcomes of spondylodiscitis cases treated with tigecycline-including therapies retrospectively.